What is Chongqing Lummy Pharmaceutical Price-to-Operating-Cash-Flow?
As of today (2025-06-04), Chongqing Lummy Pharmaceutical's share price is ¥3.71.
Chongqing Lummy Pharmaceutical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.06. Hence, Chongqing Lummy Pharmaceutical's Price-to-Operating-Cash-Flow Ratio for today is 60.82.
The historical rank and industry rank for Chongqing Lummy Pharmaceutical's Price-to-Operating-Cash-Flow or its related term are showing as below:
SZSE:300006'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 12.07 Med: 30.81 Max: 294.67
Current: 60.8
During the past 13 years, Chongqing Lummy Pharmaceutical's highest Price-to-Operating-Cash-Flow Ratio was 294.67. The lowest was 12.07. And the median was 30.81.
Chongqing Lummy Pharmaceutical's Cash Flow from Operations per share for the
three
months ended in Mar. 2025 was ¥-0.04.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.06.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Chongqing Lummy Pharmaceutical was -57.30% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 17.10% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -18.00% per year.
During the past 13 years, Chongqing Lummy Pharmaceutical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 54.40% per year. The lowest was -42.60% per year. And the median was 3.50% per year.
Chongqing Lummy Pharmaceutical Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Chongqing Lummy Pharmaceutical's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Lummy Pharmaceutical Price-to-Operating-Cash-Flow Chart
|
Chongqing Lummy Pharmaceutical Annual Data
|
|
Trend |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
Dec24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
26.92 |
62.57 |
70.56 |
47.69 |
20.91 |
|
Chongqing Lummy Pharmaceutical Quarterly Data
|
|
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
Sep24 |
Dec24 |
Mar25 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
21.54 |
12.12 |
16.79 |
20.91 |
56.23 |
Competitive Comparison of Chongqing Lummy Pharmaceutical's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - General subindustry, Chongqing Lummy Pharmaceutical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chongqing Lummy Pharmaceutical's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Chongqing Lummy Pharmaceutical's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Chongqing Lummy Pharmaceutical's Price-to-Operating-Cash-Flow falls into.
Chongqing Lummy Pharmaceutical Price-to-Operating-Cash-Flow Calculation
Chongqing Lummy Pharmaceutical's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 3.71 | / | 0.061 |
| = | 60.82 |
Chongqing Lummy Pharmaceutical's Share Price of today is ¥3.71.
Chongqing Lummy Pharmaceutical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.06.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Chongqing Lummy Pharmaceutical Business Description
Traded in Other Exchanges
N/A
Address
99 Yuma Road, Nan'an District, chongqing, CHN, 401123
Chongqing Lummy Pharmaceutical is a wholly-owned subsidiary of Lai America Pharmaceutical Co., Ltd. and is a professional pharmaceutical sales company in China.
Executives
Chongqing Lummy Pharmaceutical Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300006 has been successfully added to your